Phase 1 Lung Transplant Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1

Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension

Lung TransplantPulmonary Hypertension

Mayo Clinic4 enrolled1 locationNCT06770023

Recruiting

Phase 1

A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

Antibody Mediated Rejection of Lung Transplant

Washington University School of Medicine30 enrolled2 locationsNCT06990711

Recruiting

Phase 1

Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction

Chronic Lung DiseaseLung Transplant Rejection

Instituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana12 enrolled1 locationNCT06514378

Completed

Phase 1

A Randomized, Single-Dose and Multiple Dose Dose-Ranging Safety and Pharmacokinetics Study of Tacrolimus Powder for Inhalation in Healthy Adult Subjects

Prophylactic therapy of organ rejection in patients receiving allogeneic lung transplants

TFF Pharmaceuticals Australia Pty Limited64 enrolled2 locationsACTRN12620000192987